KR20050043796A - 에포틸론 d의 투여방법 - Google Patents

에포틸론 d의 투여방법 Download PDF

Info

Publication number
KR20050043796A
KR20050043796A KR1020047018759A KR20047018759A KR20050043796A KR 20050043796 A KR20050043796 A KR 20050043796A KR 1020047018759 A KR1020047018759 A KR 1020047018759A KR 20047018759 A KR20047018759 A KR 20047018759A KR 20050043796 A KR20050043796 A KR 20050043796A
Authority
KR
South Korea
Prior art keywords
epothilone
patient
intravenous infusion
days
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020047018759A
Other languages
English (en)
Korean (ko)
Inventor
존슨2세로버트쥐.
쉐릴마이클
한나앨리슨
Original Assignee
코산 바이오사이언시즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코산 바이오사이언시즈, 인코포레이티드 filed Critical 코산 바이오사이언시즈, 인코포레이티드
Publication of KR20050043796A publication Critical patent/KR20050043796A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020047018759A 2002-05-20 2003-05-20 에포틸론 d의 투여방법 Withdrawn KR20050043796A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38216602P 2002-05-20 2002-05-20
US60/382,166 2002-05-20

Publications (1)

Publication Number Publication Date
KR20050043796A true KR20050043796A (ko) 2005-05-11

Family

ID=33476529

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047018759A Withdrawn KR20050043796A (ko) 2002-05-20 2003-05-20 에포틸론 d의 투여방법

Country Status (7)

Country Link
US (1) US20040072882A1 (cg-RX-API-DMAC7.html)
EP (1) EP1575556A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006514681A (cg-RX-API-DMAC7.html)
KR (1) KR20050043796A (cg-RX-API-DMAC7.html)
CN (1) CN101389334A (cg-RX-API-DMAC7.html)
AU (1) AU2003296878A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004103267A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE350383T1 (de) * 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CN1870995A (zh) * 2003-09-02 2006-11-29 诺瓦提斯公司 使用埃坡霉素的癌症治疗
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
KR101604864B1 (ko) * 2008-04-25 2016-03-18 에이에스엠 인터내셔널 엔.브이. 텔루르와 셀렌 박막의 원자층 증착을 위한 전구체의 합성과 그 용도
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
WO2011056519A2 (en) 2009-10-26 2011-05-12 Asm International N.V. Synthesis and use of precursors for ald of group va element containing thin films
CA2927832C (en) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189698B1 (pl) * 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
AU738576B2 (en) * 1997-12-04 2001-09-20 Bristol-Myers Squibb Company A process for the reduction of oxiranyl epothilones to olefinic epothilones
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6302838B1 (en) * 1998-02-25 2001-10-16 Novartis Ag Cancer treatment with epothilones
CN100381566C (zh) * 1998-11-20 2008-04-16 科森生物科学公司 产生环氧噻酮及其衍生物的重组方法和材料
ES2273688T3 (es) * 1999-04-14 2007-05-16 Dana-Farber Cancer Institute, Inc. Procedimiento y composicion para el tratamiento de cancer.
WO2001064650A2 (en) * 2000-03-01 2001-09-07 Sloan-Kettering Institute For Cancer Research Center Synthesis of epothilones, intermediates thereto and analogues thereof
WO2001083800A2 (en) * 2000-04-28 2001-11-08 Kosan Biosciences, Inc. Heterologous production of polyketides
AU7902501A (en) * 2000-07-25 2002-02-05 Kosan Biosciences Inc Fermentation process for epothilones

Also Published As

Publication number Publication date
WO2004103267A2 (en) 2004-12-02
JP2006514681A (ja) 2006-05-11
WO2004103267A3 (en) 2008-11-27
AU2003296878A8 (en) 2009-01-08
AU2003296878A1 (en) 2004-12-13
EP1575556A2 (en) 2005-09-21
US20040072882A1 (en) 2004-04-15
CN101389334A (zh) 2009-03-18

Similar Documents

Publication Publication Date Title
EP1383490B1 (en) Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
Jones et al. A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
Stuurman et al. Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement
Jhaveri et al. A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer
Peterson et al. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models
RU2508110C2 (ru) КОМБИНАЦИЯ (А) ИНГИБИТОРА ФОСФОИНОЗИТ-3-КИНАЗЫ И (Б) МОДУЛЯТОРА ПУТИ Ras/Raf/Mek
Lee et al. Preclinical efficacy spectrum and pharmacokinetics of ixabepilone
Openshaw et al. Neurophysiological study of peripheral neuropathy after high-dose paclitaxel: lack of neuroprotective effect of amifostine
Naing et al. A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket-directed SRC inhibitor, in patients with advanced malignancies
JP2012500180A5 (cg-RX-API-DMAC7.html)
Patel et al. Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapy
KR20170094292A (ko) 근육감소증의 치료를 위한 미오스타틴 또는 액티빈 길항제
Kubo et al. Study protocol: Phase-Ib trial of nivolumab combined with metformin for refractory/recurrent solid tumors
US20040072882A1 (en) Methods to administer epothilone D
US20110077260A1 (en) Methods, compositions, and kits for organ protection during systemic anticancer therapy
JP2026503515A (ja) 非ホジキンリンパ腫治療用医薬組成物及びその使用
Sessa et al. Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors
Sang et al. Design strategies for long-acting anti-HIV pharmaceuticals
JP2007508299A (ja) 全身性抗癌治療の間の器官保護のための方法、組成物、およびキット
Gao et al. Preclinical development and phase I study of ZSYY001, a polymeric micellar paclitaxel for advanced solid tumor
Lin et al. Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo
Zhang et al. Bioevaluation of a dual PI3K/HDAC inhibitor for the treatment of diffuse large B-cell lymphoma
EP2023923A2 (en) Use of ixabepilone in combination with cyp3a4 inhibitors for pharmaceuticals
Konner et al. Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
Zhang et al. Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20041119

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid